Skip to main content

ADVERTISEMENT

bare-metal stent

Dr Mathews
AMP 2023
12/05/2023

S. Jay Mathews, MD
Bradenton Cardiology Center, Bradenton, Florida

S. Jay Mathews, MD Bradenton Cardiolo...
Watch as Dr. S. Jay Mathews, interventional cardiologist from Bradenton Cardiology Center in Florida, discusses his presentation at AMP 2023 on the Bare Temporary Spur Stent System (Reflow Medical), which is a unique approach to the...
Watch as Dr. S. Jay Mathews, interventional cardiologist from Bradenton Cardiology Center in Florida, discusses his presentation at AMP 2023 on the Bare Temporary Spur Stent System (Reflow Medical), which is a unique approach to the...
Watch as Dr. S. Jay Mathews,...
12/05/2023
Vascular Disease Management
Original Contribution
06/06/2021

Andrew Kei-Yan Ng, MBBS1;  Pauline Yeung Ng, MBBS2,3

Chung-Wah Siu, MD4;  Man-Hong Jim, MD1

Andrew Kei-Yan Ng, MBBS1;  Pauline Ye...
The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.
The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.
The study objective is to...
06/06/2021
Journal of Invasive Cardiology
Comparison Between Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Bioresorbable Vascular Scaffolds
06/01/2021

Andrew Kei-Yan Ng, MBBS1;  Pauline Yeung Ng, MBBS2,3;  Chung-Wah Siu, MD4;  Man-Hong Jim, MD1

Andrew Kei-Yan Ng, MBBS1;  Pauline Ye...
The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.
The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.
The study objective is to...
06/01/2021
Journal of Invasive Cardiology
Clinical Images
12/28/2018

Mohammed Alomar, MD;  Rajiv Tayal, MD, MPH;  Michael Amponsah, MD;  Marc Cohen, MD;  Najam Wasty, MD

Mohammed Alomar, MD;  Rajiv Tayal, MD...
Contrary to popular wisdom, predominantly unilateral aortoiliac bifurcation disease can be safely treated with a single stent if the contralateral common iliac ostium is protected with matching balloon inflation.
Contrary to popular wisdom, predominantly unilateral aortoiliac bifurcation disease can be safely treated with a single stent if the contralateral common iliac ostium is protected with matching balloon inflation.
Contrary to popular wisdom,...
12/28/2018
Journal of Invasive Cardiology
Original Contribution
09/15/2017

Alexander Volodarskiy, MD1;  Sunil Kumar, MD2;  Radoslaw Pracon, MD3;  Mandeep Sidhu, MD5;  Evgeny Kretov, MD5; Tomasz Mazurek, MD6;  Olga Bockeria, MD7;  Upendra Kaul, MD8;  Sripal Bangalore, MD, MHA9

 

Alexander Volodarskiy, MD1;  Sunil Ku...
This study evaluates the outcomes of drug-eluting vs bare-metal stent with implantation in patients with chronic kidney disease.
This study evaluates the outcomes of drug-eluting vs bare-metal stent with implantation in patients with chronic kidney disease.
This study evaluates the...
09/15/2017
Journal of Invasive Cardiology
Original Contribution
11/15/2016

Wassim Mosleh, MB, BCh, BAO1;  Sumeet Gandhi, MD2;  Mohamed Elsiddig, MB, BCh, BAO3;  Jon-David Schwalm, MD, MSc2;  Michael E. Farkouh, MD, MSc4

Wassim Mosleh, MB, BCh, BAO1;  Sumeet...
The results of this large meta-analysis suggest that patients with DES (n = 39,213) in comparison with BMS implantation (n = 26,461) for PCI to SVG lesions had lower MACE, all-cause mortality, and TVR rates, without a significant reduction in...
The results of this large meta-analysis suggest that patients with DES (n = 39,213) in comparison with BMS implantation (n = 26,461) for PCI to SVG lesions had lower MACE, all-cause mortality, and TVR rates, without a significant reduction in...
The results of this large...
11/15/2016
Journal of Invasive Cardiology
Review
09/18/2009
The development of bare-metal stents (BMS) and optimal post-procedure antiplatelet therapy in the mid 1990s resulted in marked reductions in acute and subacute stent thrombosis, bleeding complications, negative remodeling, and acute vessel...
The development of bare-metal stents (BMS) and optimal post-procedure antiplatelet therapy in the mid 1990s resulted in marked reductions in acute and subacute stent thrombosis, bleeding complications, negative remodeling, and acute vessel...
The development of bare-metal...
09/18/2009
Vascular Disease Management